Stock comparison
Geron
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
GERN
Geron
Market cap
$821.15M
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | GERN | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 36D | 69B | MTD |
| Benjamin Graham | 63D | 65B | MTD |
| Philip Fisher | 52C | 63C | MTD |
| Peter Lynch | 20F | 66B | MTD |
| Joel Greenblatt | 2F | 68B | MTD |
| Charlie Munger | 43D | 74B | MTD |
| Terry Smith | 48D | 70B | MTD |
Side-by-side metrics
| Metric | GERN | MTD |
|---|---|---|
| Market cap | $821.15M | $22.29B |
| P/E (TTM) | - | 25.3x |
| EV/EBIT | - | 21.6x |
| ROIC (TTM) | -7.77% | 36.09% |
| Gross margin | 86.59% | 57.79% |
| Net margin | -35.48% | 21.4% |
| Revenue CAGR 5y | 2.39% | 2.01% |
| EPS CAGR 5y | - | 6.12% |
| Debt / Equity | 1.1x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GERN leads on
- EV/EBIT-vs 21.6x+183%
- P/E (TTM)-vs 25.3x+147%
- Revenue CAGR 5y2.39%vs 2.01%+99%
- Gross margin86.59%vs 57.79%+33%
MTD leads on
- Net margin21.4%vs -35.48%+160%
- ROIC (TTM)36.09%vs -7.77%+122%
- Debt / Equity-vs 1.1x+102%
- Market cap$22.29Bvs $821.15M+96%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.